BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38172600)

  • 1. Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer.
    Chae J; Jung SH; Choi EJ; Kim JW; Kim NY; Moon SW; Lee JY; Chung YJ; Lee SH
    Exp Mol Med; 2024 Feb; 56(1):168-176. PubMed ID: 38172600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-exome sequencing of Nigerian benign prostatic hyperplasia reveals increased alterations in apoptotic pathways.
    White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Thorpe RJ; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Yates C
    Prostate; 2024 Apr; 84(5):460-472. PubMed ID: 38192023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.
    Buhigas C; Warren AY; Leung WK; Whitaker HC; Luxton HJ; Hawkins S; Kay J; Butler A; Xu Y; Woodcock DJ; Merson S; Frame FM; Sahli A; Abascal F; ; Martincorena I; Bova GS; Foster CS; Campbell P; Maitland NJ; Neal DE; Massie CE; Lynch AG; Eeles RA; Cooper CS; Wedge DC; Brewer DS
    Mol Cancer; 2022 Sep; 21(1):183. PubMed ID: 36131292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte Telomere Length and the Risk of Prostate Cancer and Benign Prostatic Hyperplasia: Insights From UK Biobank and Mendelian Randomization Study.
    Lv K; Wu Y; Yang G; Hao X; Huang S; Song T; Yuan Q
    J Gerontol A Biol Sci Med Sci; 2024 Mar; 79(3):. PubMed ID: 38085929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ-wide telomeric status in diseased and disease-free prostatic tissues.
    Heaphy CM; Fleet TM; Treat EG; Lee SJ; Smith AY; Davis MS; Griffith JK; Fischer EG; Bisoffi M
    Prostate; 2010 Sep; 70(13):1471-9. PubMed ID: 20687220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Cancer-Associated Gene Mutations in Urinary Cell-Free DNA among Prostate Cancer Patients in South Africa.
    Temilola DO; Wium M; Paccez J; Salukazana AS; Rotimi SO; Otu HH; Carbone GM; Kaestner L; Cacciatore S; Zerbini LF
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma.
    Chopra DP; Grignon DJ; Joiakim A; Mathieu PA; Mohamed A; Sakr WA; Powell IJ; Sarkar FH
    J Cell Physiol; 1996 Nov; 169(2):269-80. PubMed ID: 8908194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology.
    Parr RL; Dakubo GD; Crandall KA; Maki J; Reguly B; Aguirre A; Wittock R; Robinson K; Alexander JS; Birch-Machin MA; Abdel-Malak M; Froberg MK; Diamandis EP; Thayer RE
    J Mol Diagn; 2006 Jul; 8(3):312-9. PubMed ID: 16825503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancer.
    Schlechte H; Lenk SV; Löning T; Schnorr D; Rudolph BD; Ditscherlein G; Loening SA
    Eur Urol; 1998; 34(5):433-40. PubMed ID: 9803007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Prostate Size and MRI Determined Quantitative Prostate Zonal Measurements.
    Sellers J; Wagstaff R; Helo N; de Riese WTW
    Res Rep Urol; 2022; 14():265-274. PubMed ID: 35795724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review.
    Al-Khalil S; Boothe D; Durdin T; Sunkara S; Watkins P; Yang S; Haynes A; de Riese W
    Int Urol Nephrol; 2016 Jan; 48(1):91-7. PubMed ID: 26590832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
    Haese A; Graefen M; Noldus J; Hammerer P; Huland E; Huland H
    J Urol; 1997 Dec; 158(6):2188-92. PubMed ID: 9366341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenotyping of angiotensin-converting enzyme in the prostate in patients with prostate cancer and benign prostatic hyperplasia].
    Mamedov VN; Danilov SM; Samokhodskaya LM; Okhobotov DA; Kamalov DM; Melnikov N; Karpov VK; Kadrev AV; Kamalov AA
    Urologiia; 2020 Nov; (5):20-27. PubMed ID: 33185341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer.
    Ahmed R; Lozano LE; Anastasio A; Lofek S; Mastelic-Gavillet B; Navarro Rodrigo B; Nguyen S; Dartiguenave F; Rodrigues-Dias SC; Cesson V; Valério M; Roth B; Kandalaft LE; Redchenko I; Hill AVS; Harari A; Romero P; Derré L; Viganó S
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Microbial Signature Associated With Benign Prostatic Hyperplasia and Prostate Cancer.
    Sarkar P; Malik S; Banerjee A; Datta C; Pal DK; Ghosh A; Saha A
    Front Cell Infect Microbiol; 2022; 12():894777. PubMed ID: 35865814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.
    Su Z; Wang G; Li L
    Cancer Biomark; 2023; 38(2):143-159. PubMed ID: 37781794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic Resonance Imaging Detection of Glucose-Stimulated Zinc Secretion in the Enlarged Dog Prostate as a Potential Method for Differentiating Prostate Cancer From Benign Prostatic Hyperplasia.
    Khalighinejad P; Parrott D; Jordan VC; Chirayil S; Preihs C; Rofsky NM; Xi Y; Sherry AD
    Invest Radiol; 2021 Jul; 56(7):450-457. PubMed ID: 34086013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Progression of High Grade Prostatic Intraepithelial Neoplasia to Prostate Cancer.
    Jung SH; Shin S; Kim MS; Baek IP; Lee JY; Lee SH; Kim TM; Lee SH; Chung YJ
    Eur Urol; 2016 May; 69(5):823-30. PubMed ID: 26542946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prostate size and glandular tissue volume of the peripheral zone via novel combined MRI and histopathology: possible pathophysiological implications on prostate cancer development.
    Lin B; Cavdar IK; Buxton M; Sellers J; Brandi L; Helo N; de Riese WTW
    Int Urol Nephrol; 2023 Apr; 55(4):835-844. PubMed ID: 36739353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.